This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AMGN, DOW, GDOT, S, XOM


AmerisourceBergen (ABC) upgraded at Baird from Neutral to Outperform, Robert Baird said. $46 price target. Comps are easing and earnings growth should accelerate.

Amgen (AMGN - Get Report) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $95 price target. Base business appears to have stabilized.

Acme Packet (APKT) downgraded at Pacific Crest to Sector Perform, Pacific Crest said. Company is seeing lower orders from its largest customers.

BGC Partners (BGCP) downgraded to hold at TheStreet Ratings.

Boston Scientific (BSX) downgraded to sell at TheStreet Ratings.

Colgate-Palmolive (CL) downgraded at Deutsche to Hold, Deutsche Bank said. Valuation call, based on a $105 price target.

Coinstar (CSTR) downgraded at Pacific Crest from Outperform to Sector Perform, Pacific Crest said. Company is seeing slower growth at Redbox.

Dow Chemical (DOW - Get Report) downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Company faces macro headwinds in the near- and medium-term.

Emcor (EME) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $26 price target. Organic backlog continues to decline.

Expedia (EPXE) upgraded at Morgan Stanley to Equal-weight, Morgan Stanley said. Company has solid sales growth momentum.

Green Dot (GDOT - Get Report) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $20 price target. Estimates also cut, as the company slashed its guidance.

Green Dot downgraded at JMP from Outperform to Market Perform, JMP Securities said. Estimates also cut, as the company is facing increased competition.

Green Dot downgraded at KBW from Outperform to Market Perform, Keefe, Bruyette & Woods said. Estimates also cut, given the company's new guidance. $20 price target.

HealthSouth Corporation (HLS) downgraded at Jefferies to Hold from Buy, Jefferies said. $23 price target. Rate risk rises. Hold rating.

Snyder's-Lance (LNCE) rated new Hold at Deutsche Bank. Valuation call, based on a $24 price target.

MetroPCS (PCS) upgraded at Deutsche to Buy. $12 price target. Stock still has another 40% upside potential, as expectations remain low.

QLogic (QLGC) downgraded at Pacific Crest to Underperform, Pacific Crest said. Business is in a secular decline.

Raytheon (RTN) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $56 price target.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AMGN $149.26 -0.43%
DOW $47.13 -1.40%
GDOT $18.60 0.51%
S $4.50 -1.10%
XOM $78.97 -1.30%


Chart of I:DJI
DOW 17,055.06 +4.31 0.03%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,818.9840 +8.1960 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs